Furthermore, miR-223-3p negatively regulates activation of the NLRP3 inflammasome by downregulating expression of NLRP3, IL-1β, and activation of caspase-1 in both endotoxin acute hepatitis and fibrotic NASH (84). Here, NLRP3 is linked to metabolic dysfunction-associated steatohepatitis.